A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Publication | Closed Access

DOI

Citations

References

2017

Year

Robbert J. de Winter, Yuki Katagiri, Taku Asano, Krzysztof Milewski, Philipp Lurz, Paweł Buszman, Gillian A.J. Jessurun, Karel T. Koch, Roland P.T. Troquay, Bas Hamer,

The Lancet

Percutaneous Coronary InterventionCardiovascular DiseaseLumen-apposing Metal StentSurgeryBiomedical EngineeringMedicineDessolve IiiCardiologyCoronary Artery DiseaseAcute Myocardial Infarction